Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil
Clinical trial NCT03330899 · COMPLETED
Trial details
- NCT number
- NCT03330899
- Sponsor
- Butantan Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-24
- Primary completion
- 2020-01-30
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.